Ferric carboxymaltose versus ferric gluconate in hemodialysis patients: Reduction of erythropoietin dose in 4 years of follow-up

• मुख्य लेखकों: Antonio Lacquaniti (लेखक), Patrizio Pasqualetti (लेखक), Teresa Casuscelli di Tocco (लेखक), Susanna Campo (लेखक), Stefania Rovito (लेखक), Maurizio Bucca (लेखक), Antonino Ragusa (लेखक), Paolo Monardo (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: The Korean Society of Nephrology, 2020-09-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Background : : Ferric carboxymaltose (FCM) is a parenteral, dextran-free iron formulation designed to overcome the limitations of existing iron preparations. The main aim of this study was to retrospectively examine results obtained from a long period of FCM therapy in hemodialysis patients who have...